RxDoctor Payments Data

Carlos Pinheiro Neto, MD

Otolaryngology · Rochester, MNNPI 1831403237

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $9,328 of the $10,774 with a category attached, or 86.6%. Zimmer Biomet accounts for 66.2% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2019 at $7,128 and has fallen 94.6% since, to $388 in 2025. Among otolaryngology clinicians in MN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$10,774in general payments, 2019–2025

Across 22 payments — averaging $489.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Zimmer Biomet$7K
  • Medical Device Business Services, Inc.$2K
  • Stryker$695
  • Integra Lifesciences Corporation$267
  • Acclarent, Inc$134
  • Sanofi Pasteur Inc.$113
  • plus $20 from 1 others

What the payments were for

  • Consulting fees$9,32887%
  • Travel & lodging$4164%
  • Food & beverage$1,03110%

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,774 in reported general payments places this provider in the 90th percentile of 181 otolaryngology providers in Minnesota.

See all otolaryngology providers in Minnesota

Medicare billing

Part B allowed, 2024
$127,781
Medicare patients
115
Services billed
382

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Budesonide13$3,961
Ipratropium Bromide53$1,235

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Rochester

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →